MedPath

Study on urological cancer diagnosis, prediction for stage and treatment effect by comprehensive serum glycopeptide spectra analysis(prostate cancer, urothelial cancer, renal cell carcinoma)

Not Applicable
Recruiting
Conditions
rological cancer
Registration Number
JPRN-UMIN000042777
Lead Sponsor
Tokai University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
800
Inclusion Criteria

Not provided

Exclusion Criteria

1. Person who are considered as worsen their health condition due to blood test. 2. Person who are regarded as inappropriate for the study by the researcher.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation analysis between comprehensive serum glycopeptide profile analysis and diagnosis of the presence or absence of cancer, staging, efficacy for treatment, diagnostic imaging findings, and histopathological findings
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath